Laurence Rodriguez
Chief Executive Officer at GENSIGHT BIOLOGICS S.A.
Network origin in Laurence Rodriguez first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Laurence Rodriguez via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Universite Paris Cite | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| Ecole Supérieure de Gestion et Finances | College/University | Graduate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree | |
Raptor Pharmaceuticals Europe BV
 Raptor Pharmaceuticals Europe BV Miscellaneous Commercial ServicesCommercial Services Part of Amgen, Inc., Raptor Pharmaceuticals Europe BV is a Dutch company that engages in research and experimental development in other physical and natural sciences. The company is based in Louveciennes, the Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Suffolk University | College/University | Undergraduate Degree | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director of Finance/CFO | |
| IPSEN | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| IQVIA | Corporate Officer/Principal | ||
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
Priothera SAS
 Priothera SAS BiotechnologyHealth Technology Part of Priothera Ltd., Priothera SAS is a French company dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of both allogeneic hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy. The company is based in Saint-Louis, France. Priothera is leading the way in developing Mocravimod, a S1P receptor modulator as an adjunctive and maintenance immune therapy to allo-HSCT and to CAR-T. Mocravimod has the potential to reduce the occurrence of (acute) GVHD without suppressing T cell function, thus GVL is maintained. Priothera is developing Mocravimod (KRP203) to significantly improve the clinical outcome of allo-HSCT and CAR-T therapy. The company was founded in 2020 by Philippe Lievre, Florent Gros, Brice R. Suire, Stephan Oehen, Simone Seiter. Florent Gros has been the CEO since 2020. | Biotechnology | Founder | |
| Neu-Ulm University of Applied Sciences | College/University | Masters Business Admin | |
| NEOMA Business School | College/University | Graduate Degree | |
Bamboo Therapeutics, Inc.
 Bamboo Therapeutics, Inc. BiotechnologyHealth Technology Bamboo Therapeutics, Inc. develops gene therapy products for central nervous system and neuromuscular diseases. Its therapeutic platform is based on the use of Adeno-associated virus as a gene therapy vehicle. The company’s proprietary technologies include chimeric vectors, self-complementary vectors, and dual glycan receptor. It focuses on the treatment of Duchenne muscular dystrophy, giant axonal neuropathy, Friedreich ataxia, and Canavan disease. Bamboo Therapeutics was founded by Richard Jude Samulski, Sheila A. Mikhail, Josh Grieger, Xiao Xiao, and Paola Leone in December 2014 and is headquartered in Chapel Hill, NC. | Biotechnology | General Counsel | |
Biologics Consulting Group, Inc.
 Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MAINSTAY MEDICAL INTERNATIONAL | Medical Specialties | Director/Board Member | |
| Life Sciences Acceleration Alliance eV | Director/Board Member | ||
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member | |
| Healthtech For Care | Corporate Officer/Principal | ||
| Sorbonne Université | College/University | Graduate Degree | |
| REGENXBIO INC. | Pharmaceuticals: Major | General Counsel | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | General Counsel | |
| The University of Chicago | College/University | Doctorate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | Director/Board Member | |
| Advanced Therapies Partners LLC | President | ||
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Corporate Officer/Principal | |
| Standards Coordinating Body | Director/Board Member | ||
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Chief Operating Officer | |
Boston Consulting Group SAS
 Boston Consulting Group SAS Miscellaneous Commercial ServicesCommercial Services Boston Consulting Group SAS operates as a management consulting firm. It provides business and other consultancy services. The company is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Universitat Pompeu Fabra | College/University | Graduate Degree | |
| University of Salford | College/University | Graduate Degree | |
| Académie nationale de Pharmacie | Corporate Officer/Principal | ||
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Corporate Officer/Principal | |
| Ecole Polytechnique De L'universite Paris-sud | College/University | Undergraduate Degree | |
| MAUNA KEA TECHNOLOGIES | Medical Specialties | Chief Tech/Sci/R&D Officer | |
GFAL Ltd.
 GFAL Ltd. Real Estate Investment TrustsFinance Part of GGL Group Number Two Ltd., GFAL Ltd. is a British company that provides property investment services. The company is based in London, UK and was founded in 2015. | Real Estate Investment Trusts | Chief Executive Officer | |
| University of Warwick | College/University | Undergraduate Degree | |
| The Open University Business School | College/University | Masters Business Admin | |
| Université Paris-Saclay | College/University | Doctorate Degree |
Statistics
International
| France | 19 |
| United States | 19 |
| Germany | 5 |
| United Kingdom | 5 |
| Netherlands | 3 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 18 |
| Commercial Services | 6 |
| Finance | 3 |
| Government | 2 |
Operational
| Director/Board Member | 52 |
| Corporate Officer/Principal | 31 |
| Chairman | 24 |
| Independent Dir/Board Member | 19 |
| Founder | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Bernard Gilly | 32 |
| Michael Wyzga | 31 |
| Cédric Moreau | 14 |
| Maritza McIntyre | 14 |
| Elsy Boglioli Hofman | 14 |
| Peter Goodfellow | 13 |
| Philippe Motté | 8 |
| Françoise de Craecker | 7 |
| Leigh Shaw | 6 |
| Simone Seiter | 6 |
| Scott Jeffers | 5 |
| Thomas Gidoin | 5 |
| Magali Taiel | 4 |
| Marion Ghibaudo | 4 |
| Sissel Rodahl | 4 |
- Stock Market
- Insiders
- Laurence Rodriguez
- Company connections
